In many cancers, however, MYC is frequently overexpressed and hyperactivated through gene translocations, amplifications or upstream oncogenic signalling stimulation, resulting in elevated levels of rRNAs, RPs, RBFs, and key translation initiation components such as the eIF4F complex and 5′ mRNA cap-methylation machinery [140,141]. The gene discussed is MYC; the disease is cancer.